๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized study: Small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy

โœ Scribed by Richard M. Fox; Robert L. Woods; Graeme N. Brodie; Martin H.N. Tattersall

Publisher
Elsevier Science
Year
1980
Tongue
English
Weight
330 KB
Volume
6
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Urokinase combination chemotherapy in sm
Urokinase combination chemotherapy in small cell lung cancer. A phase II study
โœ F. A. Calvo; O. F. Hidalgo; F. Gonzalez; J. Rebollo; S. Martin Algarra; D. Ortiz ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 770 KB

## Background and methods: Fifty-one patients with small cell lung cancer (sclc) were treated with alternating urokinase (uk)-cyclophosphamide-doxorubicin (adriamycin, adria laboratories, columbus, oh)-vincristine and cisplatin-etoposide-vincristine. uk was given as a loading dose of 3000 microgram

Combination chemotherapy with cisplatin
Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer
โœ F. Figoli; A. Veronesi; M. G. Trovo; D. Errante; M. Della Valentina; V. Zagonel; ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 447 KB

A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)